Rui Sun

Anti-CD19 Chimeric Antigen Receptor T Cells in Combination With Nivolumab Are Safe and Effective Against Relapsed/Refractory B-Cell Non-hodgkin Lymphoma

Yaqing Cao, Wenyi Lu, Rui Sun et al. · Frontiers in Oncology · 2019 · 155 citations · Full text

Life Sciences, Immunology, Oncology +17

Polygenic Analysis of Late-Onset Alzheimer’s Disease from Mainland China

Bin Jiao, Xiaoyan Liu, Lin Zhou et al. · PLoS ONE · 2015 · 83 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Low‐dose decitabine plus venetoclax is safe and effective as post‐transplant maintenance therapy for high‐risk acute myeloid leukemia and myelodysplastic syndrome

Yunxiong Wei, Xia Xiong, Xin Li et al. · Cancer Science · 2021 · 71 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

A novel bispecific antibody targeting CD3 and prolactin receptor (PRLR) against PRLR-expression breast cancer

Yuexian Zhou, Huifang Zong, Lei Han et al. · Journal of Experimental & Clinical Cancer Research · 2020 · 62 citations · Full text

Life Sciences, Immunology, Oncology +17

Modified Paclitaxel-loaded Nanoparticles for Inhibition of Hyperplasia in a Rabbit Arterial Balloon Injury Model

Lin Mei, Hongfan Sun, Xu Jin et al. · Pharmaceutical Research · 2007 · 40 citations

Pharmacy, Pharmaceutics, Pharmacology +14